Bit from BP report
"Earnings revisions We have upgraded our underlying EPS by 0.3%, 20.3% and 17.0% for FY16, FY17 and FY18 respectively. The earnings revision is driven by the following three factors: New contract win (JBWere) worth ~$1m in revenue pa; A stronger AUD/GBP cross rate reducing the loss from the UK operations; and Offset to a degree by weaker net-flow and mark-to-market estimates. Following the changes our revised Price Target is $0.62 per share (previously $0.56 per share). Our Buy recommendation remains unchanged."
- Forums
- ASX - By Stock
- PPS
- Ann: Praemium sign up JBWere-PPS.AX
Ann: Praemium sign up JBWere-PPS.AX, page-6
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PPS (ASX) to my watchlist
(20min delay)
|
|||||
Last
66.5¢ |
Change
0.005(0.76%) |
Mkt cap ! $250.6M |
Open | High | Low | Value | Volume |
67.0¢ | 67.0¢ | 65.5¢ | $184.6K | 279.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3498 | 65.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
66.5¢ | 3270 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7000 | 0.590 |
1 | 52000 | 0.575 |
6 | 111190 | 0.570 |
2 | 35080 | 0.565 |
5 | 50580 | 0.560 |
Price($) | Vol. | No. |
---|---|---|
0.600 | 131318 | 9 |
0.605 | 48960 | 3 |
0.610 | 44045 | 4 |
0.615 | 78993 | 6 |
0.620 | 110891 | 5 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
PPS (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online